Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2013

01-11-2013 | Poster presentation

PB.28: Is second-time vacuum-assisted biopsy effective in improving preoperative diagnosis rate of screen-detected DCIS?

Authors: S Pattison, A Kumar, W Teh, R Patel

Published in: Breast Cancer Research | Special Issue 1/2013

Login to get access

Excerpt

The NHSBSP standards for non-operative diagnosis are a target of 95% for invasive cancers (minimum 90%) and 90% for non-invasive cancer (minimum 85%). The lower target for non-invasive cancers reflects the difficulty in achieving definitive diagnosis of DCIS. Our unit has routinely used vacuum biopsies (VAB) for non-operative diagnosis of microcalcifications. Following an audit in 2009, repeat VAB were extended to B3 cases selected in MDT in order to improve non-operative diagnosis of DCIS. …
Metadata
Title
PB.28: Is second-time vacuum-assisted biopsy effective in improving preoperative diagnosis rate of screen-detected DCIS?
Authors
S Pattison
A Kumar
W Teh
R Patel
Publication date
01-11-2013
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2013
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3528

Other articles of this Special Issue 1/2013

Breast Cancer Research 1/2013 Go to the issue

Poster presentation

PB.53: Are ethnic minorities more likely to develop triple-negative breast cancer? A systematic review

Poster presentation

PB.05: MRI-guided vacuum-assisted breast biopsy at 3T: initial experience

Poster presentation

PB.41: Audit of screening-detected breast cancers with discordant interpretations on double-read screening mammography

Poster presentation

PB.15: Pain in mammography: where and why does it arise?

Poster presentation

PB.06: Preliminary results in the performance comparison between the size ratio and colour scoring breast ultrasound elastographic techniques

Poster presentation

PB.04: MRI In lobular and mixed lobular/ductal carcinomas: can we preselect cases based on imaging appearance?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits